ロード中...
Infliximab Treatment of Refractory Cardiac Sarcoidosis
Treatment of cardiac sarcoidosis is challenging, as the disease can be refractory to traditional treatment with steroids. Infliximab, a tumor necrosis factor-α inhibitor, has been reportedly used in cardiac sarcoidosis, but published evidence is limited. The potential cardiotoxicity of infliximab an...
保存先:
| 出版年: | JACC Case Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8302154/ https://ncbi.nlm.nih.gov/pubmed/34317016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2020.06.041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|